Neuroscience & Pain Research Laboratory, Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology, Banaras Hindu University Varanasi-221005, Uttar Pradesh, India.
ACS Chem Neurosci. 2020 Mar 18;11(6):830-839. doi: 10.1021/acschemneuro.0c00019. Epub 2020 Mar 9.
The opioid crisis is a major threat of the 21st century, with a remarkable juxtaposition of use and abuse. Opioids are the most potent and efficacious class of analgesics, but despite their proven therapeutic efficacy, they have recently been degraded to third-line therapy for the management of chronic pain in clinics. The reason behind this is the development of potential side effects and tolerance after repeated dosing. Opioid tolerance is the major limiting factor leading to the withdrawal of treatment, severe side effects due to dose escalation, and sometimes even death of the patients. Every day more than 90 people die due to opioids overdose in America, and a similar trend has been seen across the globe. Over the past two decades, researchers have been trying to dissect the neurobiological mechanism of opioid tolerance. Research on opioid tolerance shifted toward central nervous system-based adaptations because tolerance is much more than just a cellular phenomenon. Thus, neurobiological adaptations associated with opioid tolerance are important to understand in order to find newer pain therapeutics. These adaptations are associated with alterations in ascending and descending pain pathways, reward circuitry modulations, receptor desensitization and down-regulation, receptor internalization, heterodimerization, and altered epigenetic regulation. The present Review is focused on novel circuitries associated with opioid tolerance in different areas of the brain, such as periaqueductal gray, rostral ventromedial medulla, dorsal raphe nucleus, ventral tegmental area, and nucleus accumbens. Understanding the neurobiological modulations associated with chronic opioid exposure and tolerance will pave the way for the development of novel pharmacological tools for safer and better management of chronic pain in patients.
阿片类药物危机是 21 世纪的主要威胁,存在着显著的使用和滥用并存的情况。阿片类药物是最有效和最有效的一类镇痛药,但尽管它们具有经过验证的治疗效果,但最近在临床上已将其降级为治疗慢性疼痛的三线治疗药物。背后的原因是在重复给药后会产生潜在的副作用和耐受性。阿片类药物耐受是导致治疗中断、因剂量增加而导致严重副作用甚至患者死亡的主要限制因素。每天在美国有超过 90 人因阿片类药物过量而死亡,全球也出现了类似的趋势。在过去的二十年中,研究人员一直在努力剖析阿片类药物耐受的神经生物学机制。阿片类药物耐受的研究转向了基于中枢神经系统的适应性,因为耐受不仅仅是一种细胞现象。因此,了解与阿片类药物耐受相关的神经生物学适应性对于寻找新的疼痛治疗方法非常重要。这些适应性与上行和下行疼痛途径的改变、奖励回路的调节、受体脱敏和下调、受体内化、异二聚体化以及表观遗传调控的改变有关。本综述重点介绍了与大脑不同区域的阿片类药物耐受相关的新回路,例如导水管周围灰质、吻侧腹内侧髓质、中缝背核、腹侧被盖区和伏隔核。了解与慢性阿片类药物暴露和耐受相关的神经生物学调节将为开发新的药理学工具铺平道路,以更安全、更好地管理慢性疼痛患者。